194 related articles for article (PubMed ID: 21820033)
1. Post-translational modification of the androgen receptor.
Gioeli D; Paschal BM
Mol Cell Endocrinol; 2012 Apr; 352(1-2):70-8. PubMed ID: 21820033
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational modification of the androgen receptor in prostate cancer.
van der Steen T; Tindall DJ; Huang H
Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
[TBL] [Abstract][Full Text] [Related]
3. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
Lumahan LEV; Arif M; Whitener AE; Yi P
Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
[TBL] [Abstract][Full Text] [Related]
4. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the androgen receptor by post-translational modifications.
Coffey K; Robson CN
J Endocrinol; 2012 Nov; 215(2):221-37. PubMed ID: 22872761
[TBL] [Abstract][Full Text] [Related]
6. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
[TBL] [Abstract][Full Text] [Related]
7. ARD1/NAA10 acetylation in prostate cancer.
Kuhns KJ; Zhang G; Wang Z; Liu W
Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
[TBL] [Abstract][Full Text] [Related]
8. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG
J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
[TBL] [Abstract][Full Text] [Related]
10. The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.
Mukherjee S; Cruz-Rodríguez O; Bolton E; Iñiguez-Lluhí JA
J Biol Chem; 2012 Sep; 287(37):31195-206. PubMed ID: 22829593
[TBL] [Abstract][Full Text] [Related]
11. Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor.
Bai S; Wilson EM
Mol Cell Biol; 2008 Mar; 28(6):1947-63. PubMed ID: 18212060
[TBL] [Abstract][Full Text] [Related]
12. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor phosphorylation: biological context and functional consequences.
Koryakina Y; Ta HQ; Gioeli D
Endocr Relat Cancer; 2014 Aug; 21(4):T131-45. PubMed ID: 24424504
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modification-dependent androgen receptor occupancy facilitates the ectopic TSPY1 expression in prostate cancer cells.
Leng X; Liu M; Tao D; Yang B; Zhang Y; He T; Xie S; Wang Z; Liu Y; Yang Y
Cancer Sci; 2021 Feb; 112(2):691-702. PubMed ID: 33185915
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor signalling in prostate cancer: the functional consequences of acetylation.
Lavery DN; Bevan CL
J Biomed Biotechnol; 2011; 2011():862125. PubMed ID: 21274273
[TBL] [Abstract][Full Text] [Related]
18. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
19. Analysis of androgen receptor SUMOylation.
Rytinki MM; Kaikkonen S; Sutinen P; Palvimo JJ
Methods Mol Biol; 2011; 776():183-97. PubMed ID: 21796528
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-like protein modifications in prostate and breast cancer.
Wu F; Mo YY
Front Biosci; 2007 Jan; 12():700-11. PubMed ID: 17127330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
